Substituted pyrrolidines
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Sep 9, 1997
Grant Date -
N/A
app pub date -
Sep 20, 1993
filing date -
Sep 20, 1993
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
Novel pyrrolidine compounds which are useful for inhibiting the function of Type IV phosphodiesterase (PDE-IV) as well as methods for making the same are disclosed. Applications in treating inflammatory diseases and other diseases involving elevated levels of cytokines, as well as central nervous system (CNS) disorders, are also disclosed.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully